The study looked at how immature immune cells could predict a patient's chances of survival following a heart attack.

States sue over whether Medicaid work requirement exemptions could force medically frail enrollees to prove they are “sick ...

A softer market makes diversification easier because more insurers are competing for the same risks. Where a single carrier ...

The robotaxi service that has some excited and others wary has begun its testing of vehicles driving autonomously around ...

For children with suspected rare diseases, access to timely genomic testing remains uneven and, too often, out of reach. Too many families are left stranded in the gap between what insurance covers on ...

Thousands of California drivers have been ordered to repeat part of the licensing process after officials uncovered ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, ...

Mass General Brigham has started offering a blood test that estimates a person’s inherited risk for eight different ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered ...